renalware-core 2.0.0.pre.beta5 → 2.0.0.pre.beta6
Sign up to get free protection for your applications and to get access to all the features.
- checksums.yaml +4 -4
- data/app/assets/javascripts/renalware/session_timeout_redirect.js.erb +8 -4
- data/app/assets/stylesheets/renalware/partials/_navigation.scss +2 -2
- data/app/controllers/renalware/admin/users_controller.rb +3 -3
- data/app/helpers/renalware/application_helper.rb +2 -1
- data/app/helpers/renalware/layout_helper.rb +2 -2
- data/app/views/renalware/clinical/body_compositions/_form.html.slim +6 -2
- data/app/views/renalware/clinical/body_compositions/new.html.slim +4 -3
- data/app/views/renalware/clinics/clinic_visits/edit.html.slim +5 -2
- data/app/views/renalware/events/swabs/edit.html.slim +4 -2
- data/app/views/renalware/hd/historical_profiles/show.html.slim +6 -3
- data/app/views/renalware/patients/alerts/_form.html.slim +1 -1
- data/app/views/renalware/renal/profiles/edit.html.slim +5 -3
- data/app/views/renalware/transplants/donor_operations/edit.html.slim +7 -3
- data/lib/breadcrumb.rb +8 -0
- data/lib/renalware/version.rb +1 -1
- data/vendor/assets/fonts/foundation-icons.eot +0 -0
- data/vendor/assets/fonts/foundation-icons.scss +594 -0
- data/vendor/assets/fonts/foundation-icons.svg +970 -0
- data/vendor/assets/fonts/foundation-icons.ttf +0 -0
- data/vendor/assets/fonts/foundation-icons.woff +0 -0
- data/vendor/assets/javascripts/renalware/iframeResizer.contentWindow.js +1108 -0
- data/vendor/assets/javascripts/renalware/iframeResizer.js +1002 -0
- data/vendor/assets/javascripts/renalware/jquery-readyselector.js +17 -0
- data/vendor/assets/javascripts/renalware/masonry.min.js +9 -0
- data/vendor/assets/javascripts/renalware/modernizr.js +3 -0
- data/vendor/assets/javascripts/renalware/mousetrap.js +1044 -0
- data/vendor/assets/javascripts/renalware/print.min.js +1 -0
- data/vendor/assets/javascripts/renalware/rails.validations.js +660 -0
- data/vendor/assets/javascripts/renalware/rails.validations.simple_form.js +46 -0
- data/vendor/assets/stylesheets/renalware/print.min.css +1 -0
- data/vendor/assets/stylesheets/renalware/select2/css/select2.css +431 -0
- data/vendor/assets/stylesheets/renalware/select2/css/select2.min.css +1 -0
- data/vendor/xsd/ukrdc/README.md +9 -0
- data/vendor/xsd/ukrdc/Schema/Allergies/Allergy.xsd +69 -0
- data/vendor/xsd/ukrdc/Schema/ClinicalRelationships/ClinicalRelationship.xsd +27 -0
- data/vendor/xsd/ukrdc/Schema/Diagnoses/CauseOfDeath.xsd +32 -0
- data/vendor/xsd/ukrdc/Schema/Diagnoses/Diagnosis.xsd +41 -0
- data/vendor/xsd/ukrdc/Schema/Diagnoses/RenalDiagnosis.xsd +41 -0
- data/vendor/xsd/ukrdc/Schema/Documents/Document.xsd +72 -0
- data/vendor/xsd/ukrdc/Schema/Encounters/Encounter.xsd +121 -0
- data/vendor/xsd/ukrdc/Schema/Encounters/TransplantList.xsd +108 -0
- data/vendor/xsd/ukrdc/Schema/Encounters/Treatment.xsd +207 -0
- data/vendor/xsd/ukrdc/Schema/FamilyHistories/FamilyHistory.xsd +42 -0
- data/vendor/xsd/ukrdc/Schema/LabOrders/LabOrder.xsd +181 -0
- data/vendor/xsd/ukrdc/Schema/Medications/Medication.xsd +88 -0
- data/vendor/xsd/ukrdc/Schema/Observations/Observation.xsd +65 -0
- data/vendor/xsd/ukrdc/Schema/Patient.xsd +87 -0
- data/vendor/xsd/ukrdc/Schema/Procedures/DialysisSession.xsd +61 -0
- data/vendor/xsd/ukrdc/Schema/Procedures/Procedure.xsd +38 -0
- data/vendor/xsd/ukrdc/Schema/Procedures/Transplant.xsd +160 -0
- data/vendor/xsd/ukrdc/Schema/Procedures/VascularAccess.xsd +49 -0
- data/vendor/xsd/ukrdc/Schema/ProgramMemberships/ProgramMembership.xsd +46 -0
- data/vendor/xsd/ukrdc/Schema/README.md +1 -0
- data/vendor/xsd/ukrdc/Schema/SocialHistories/SocialHistory.xsd +15 -0
- data/vendor/xsd/ukrdc/Schema/Surveys/Survey.xsd +143 -0
- data/vendor/xsd/ukrdc/Schema/Types/ActionCode.xsd +37 -0
- data/vendor/xsd/ukrdc/Schema/Types/Address.xsd +67 -0
- data/vendor/xsd/ukrdc/Schema/Types/CF_DMD.xsd +27 -0
- data/vendor/xsd/ukrdc/Schema/Types/CF_EDTA_COD.xsd +343 -0
- data/vendor/xsd/ukrdc/Schema/Types/CF_EDTA_PRD.xsd +356 -0
- data/vendor/xsd/ukrdc/Schema/Types/CF_HL7_0004.xsd +76 -0
- data/vendor/xsd/ukrdc/Schema/Types/CF_HL7_00204.xsd +46 -0
- data/vendor/xsd/ukrdc/Schema/Types/CF_HL7_00206.xsd +41 -0
- data/vendor/xsd/ukrdc/Schema/Types/CF_RR1.xsd +567 -0
- data/vendor/xsd/ukrdc/Schema/Types/CF_RR23.xsd +82 -0
- data/vendor/xsd/ukrdc/Schema/Types/CF_RR7_Discharge.xsd +80 -0
- data/vendor/xsd/ukrdc/Schema/Types/CF_RR7_Treatment.xsd +241 -0
- data/vendor/xsd/ukrdc/Schema/Types/CF_SNOMED.xsd +27 -0
- data/vendor/xsd/ukrdc/Schema/Types/Clinician.xsd +27 -0
- data/vendor/xsd/ukrdc/Schema/Types/CodeTableDetail.xsd +27 -0
- data/vendor/xsd/ukrdc/Schema/Types/CodedField.xsd +27 -0
- data/vendor/xsd/ukrdc/Schema/Types/CommonMetadata.xsd +23 -0
- data/vendor/xsd/ukrdc/Schema/Types/ContactDetail.xsd +55 -0
- data/vendor/xsd/ukrdc/Schema/Types/DrugProduct.xsd +41 -0
- data/vendor/xsd/ukrdc/Schema/Types/EthnicGroup.xsd +114 -0
- data/vendor/xsd/ukrdc/Schema/Types/FamilyDoctor.xsd +21 -0
- data/vendor/xsd/ukrdc/Schema/Types/LabResultItem.xsd +160 -0
- data/vendor/xsd/ukrdc/Schema/Types/LabTestItem.xsd +24 -0
- data/vendor/xsd/ukrdc/Schema/Types/Language.xsd +981 -0
- data/vendor/xsd/ukrdc/Schema/Types/Location.xsd +27 -0
- data/vendor/xsd/ukrdc/Schema/Types/NV_RR14.xsd +39 -0
- data/vendor/xsd/ukrdc/Schema/Types/Name.xsd +51 -0
- data/vendor/xsd/ukrdc/Schema/Types/Occupation.xsd +75 -0
- data/vendor/xsd/ukrdc/Schema/Types/Order.xsd +48 -0
- data/vendor/xsd/ukrdc/Schema/Types/PatientNumber.xsd +90 -0
- data/vendor/xsd/ukrdc/Schema/Types/PersonalContactType.xsd +11 -0
- data/vendor/xsd/ukrdc/Schema/Types/Result.xsd +178 -0
- data/vendor/xsd/ukrdc/Schema/UKRDC.xsd +148 -0
- metadata +78 -5
- data/lib/renalware/breadcrumb.rb +0 -10
@@ -0,0 +1,356 @@
|
|
1
|
+
<xs:schema xmlns="http://www.rixg.org.uk/" xmlns:xs="http://www.w3.org/2001/XMLSchema" targetNamespace="http://www.rixg.org.uk/">
|
2
|
+
<xs:complexType name="CF_EDTA_PRD">
|
3
|
+
<!-- Also known as RR4/RR20 -->
|
4
|
+
<xs:sequence>
|
5
|
+
<xs:element name="CodingStandard" minOccurs="0">
|
6
|
+
<xs:simpleType>
|
7
|
+
<xs:restriction base="xs:string">
|
8
|
+
<xs:enumeration value="EDTA"/>
|
9
|
+
<xs:enumeration value="EDTA2"/>
|
10
|
+
</xs:restriction>
|
11
|
+
</xs:simpleType>
|
12
|
+
</xs:element>
|
13
|
+
<xs:element name="Code" minOccurs="0">
|
14
|
+
<xs:simpleType>
|
15
|
+
<xs:restriction base="xs:string">
|
16
|
+
<xs:enumeration value="0">
|
17
|
+
<xs:annotation>
|
18
|
+
<xs:documentation>Chronic Renal Failure, Aetiology uncertain</xs:documentation>
|
19
|
+
</xs:annotation>
|
20
|
+
</xs:enumeration>
|
21
|
+
<xs:enumeration value="10">
|
22
|
+
<xs:annotation>
|
23
|
+
<xs:documentation>Glomerulonephritis, historically not examined</xs:documentation>
|
24
|
+
</xs:annotation>
|
25
|
+
</xs:enumeration>
|
26
|
+
<xs:enumeration value="11">
|
27
|
+
<xs:annotation>
|
28
|
+
<xs:documentation>Severe nephoritic syndrome with focal sclerosis (Paediatric)</xs:documentation>
|
29
|
+
</xs:annotation>
|
30
|
+
</xs:enumeration>
|
31
|
+
<xs:enumeration value="12">
|
32
|
+
<xs:annotation>
|
33
|
+
<xs:documentation>IgA nephropathy proven by immunofluoresence</xs:documentation>
|
34
|
+
</xs:annotation>
|
35
|
+
</xs:enumeration>
|
36
|
+
<xs:enumeration value="13">
|
37
|
+
<xs:annotation>
|
38
|
+
<xs:documentation>Dense deposite disease, membrano-prolif. GN Type II</xs:documentation>
|
39
|
+
</xs:annotation>
|
40
|
+
</xs:enumeration>
|
41
|
+
<xs:enumeration value="14">
|
42
|
+
<xs:annotation>
|
43
|
+
<xs:documentation>Membranous nephropathy</xs:documentation>
|
44
|
+
</xs:annotation>
|
45
|
+
</xs:enumeration>
|
46
|
+
<xs:enumeration value="15">
|
47
|
+
<xs:annotation>
|
48
|
+
<xs:documentation>Membrano-proliferative GN Type I</xs:documentation>
|
49
|
+
</xs:annotation>
|
50
|
+
</xs:enumeration>
|
51
|
+
<xs:enumeration value="16">
|
52
|
+
<xs:annotation>
|
53
|
+
<xs:documentation>Rapidly progressive GN without systemic disease (crescentic)</xs:documentation>
|
54
|
+
</xs:annotation>
|
55
|
+
</xs:enumeration>
|
56
|
+
<xs:enumeration value="17">
|
57
|
+
<xs:annotation>
|
58
|
+
<xs:documentation>Focal segmental glomeruloscerosis with nephrotic syndrome in adults </xs:documentation>
|
59
|
+
</xs:annotation>
|
60
|
+
</xs:enumeration>
|
61
|
+
<xs:enumeration value="19">
|
62
|
+
<xs:annotation>
|
63
|
+
<xs:documentation>Glomerulonephritis, historically examined</xs:documentation>
|
64
|
+
</xs:annotation>
|
65
|
+
</xs:enumeration>
|
66
|
+
<xs:enumeration value="20">
|
67
|
+
<xs:annotation>
|
68
|
+
<xs:documentation>Pyelo/Interstital nephritis - cause not specified</xs:documentation>
|
69
|
+
</xs:annotation>
|
70
|
+
</xs:enumeration>
|
71
|
+
<xs:enumeration value="21">
|
72
|
+
<xs:annotation>
|
73
|
+
<xs:documentation>Pyelo/Interstital nephritis - with neurogenic bladder</xs:documentation>
|
74
|
+
</xs:annotation>
|
75
|
+
</xs:enumeration>
|
76
|
+
<xs:enumeration value="22">
|
77
|
+
<xs:annotation>
|
78
|
+
<xs:documentation>Pyelo/Interstital nephritis - congen. obst. uropathy +/- reflux</xs:documentation>
|
79
|
+
</xs:annotation>
|
80
|
+
</xs:enumeration>
|
81
|
+
<xs:enumeration value="23">
|
82
|
+
<xs:annotation>
|
83
|
+
<xs:documentation>Pyelo/Interstital nephritis - acquired obst. uropathy</xs:documentation>
|
84
|
+
</xs:annotation>
|
85
|
+
</xs:enumeration>
|
86
|
+
<xs:enumeration value="24">
|
87
|
+
<xs:annotation>
|
88
|
+
<xs:documentation>Pyelo/Interstital nephritis - vesico-ureteric reflux no obstruction</xs:documentation>
|
89
|
+
</xs:annotation>
|
90
|
+
</xs:enumeration>
|
91
|
+
<xs:enumeration value="25">
|
92
|
+
<xs:annotation>
|
93
|
+
<xs:documentation>Pyelo/Interstital nephritis - due to urolithiasis</xs:documentation>
|
94
|
+
</xs:annotation>
|
95
|
+
</xs:enumeration>
|
96
|
+
<xs:enumeration value="29">
|
97
|
+
<xs:annotation>
|
98
|
+
<xs:documentation>Pyelo/Interstital nephritis - due to other cause (please specify)</xs:documentation>
|
99
|
+
</xs:annotation>
|
100
|
+
</xs:enumeration>
|
101
|
+
<xs:enumeration value="30">
|
102
|
+
<xs:annotation>
|
103
|
+
<xs:documentation>Tubulo interstital nephritis (not pyelonephritis)</xs:documentation>
|
104
|
+
</xs:annotation>
|
105
|
+
</xs:enumeration>
|
106
|
+
<xs:enumeration value="31">
|
107
|
+
<xs:annotation>
|
108
|
+
<xs:documentation>Nephropathy due to analgesic drugs</xs:documentation>
|
109
|
+
</xs:annotation>
|
110
|
+
</xs:enumeration>
|
111
|
+
<xs:enumeration value="32">
|
112
|
+
<xs:annotation>
|
113
|
+
<xs:documentation>Nephropathy due to cis-platinum</xs:documentation>
|
114
|
+
</xs:annotation>
|
115
|
+
</xs:enumeration>
|
116
|
+
<xs:enumeration value="33">
|
117
|
+
<xs:annotation>
|
118
|
+
<xs:documentation>Nephropathy due to Cyclosporin A</xs:documentation>
|
119
|
+
</xs:annotation>
|
120
|
+
</xs:enumeration>
|
121
|
+
<xs:enumeration value="34">
|
122
|
+
<xs:annotation>
|
123
|
+
<xs:documentation>Lead induced nephropathy (interstitial)</xs:documentation>
|
124
|
+
</xs:annotation>
|
125
|
+
</xs:enumeration>
|
126
|
+
<xs:enumeration value="39">
|
127
|
+
<xs:annotation>
|
128
|
+
<xs:documentation>Nephroapthy caused by other specific drug</xs:documentation>
|
129
|
+
</xs:annotation>
|
130
|
+
</xs:enumeration>
|
131
|
+
<xs:enumeration value="40">
|
132
|
+
<xs:annotation>
|
133
|
+
<xs:documentation>Cystic Kidney Disease - Type Unspecified</xs:documentation>
|
134
|
+
</xs:annotation>
|
135
|
+
</xs:enumeration>
|
136
|
+
<xs:enumeration value="41">
|
137
|
+
<xs:annotation>
|
138
|
+
<xs:documentation>Polycystic Kidneys - Adult Type (Dominant)</xs:documentation>
|
139
|
+
</xs:annotation>
|
140
|
+
</xs:enumeration>
|
141
|
+
<xs:enumeration value="42">
|
142
|
+
<xs:annotation>
|
143
|
+
<xs:documentation>Polycystic Kidneys = Infantile (Recessive)</xs:documentation>
|
144
|
+
</xs:annotation>
|
145
|
+
</xs:enumeration>
|
146
|
+
<xs:enumeration value="43">
|
147
|
+
<xs:annotation>
|
148
|
+
<xs:documentation>Medullary Cystic Disease - including Nephoronophthisis</xs:documentation>
|
149
|
+
</xs:annotation>
|
150
|
+
</xs:enumeration>
|
151
|
+
<xs:enumeration value="49">
|
152
|
+
<xs:annotation>
|
153
|
+
<xs:documentation>Cystic Kidney Disease - Other Specified Type</xs:documentation>
|
154
|
+
</xs:annotation>
|
155
|
+
</xs:enumeration>
|
156
|
+
<xs:enumeration value="50">
|
157
|
+
<xs:annotation>
|
158
|
+
<xs:documentation>Hereditary/Familial Nephropathy - Typoe Unspecified</xs:documentation>
|
159
|
+
</xs:annotation>
|
160
|
+
</xs:enumeration>
|
161
|
+
<xs:enumeration value="51">
|
162
|
+
<xs:annotation>
|
163
|
+
<xs:documentation>Hereditary Nephritis with Nerve Deafness (Alport's)</xs:documentation>
|
164
|
+
</xs:annotation>
|
165
|
+
</xs:enumeration>
|
166
|
+
<xs:enumeration value="52">
|
167
|
+
<xs:annotation>
|
168
|
+
<xs:documentation>Cystinosis</xs:documentation>
|
169
|
+
</xs:annotation>
|
170
|
+
</xs:enumeration>
|
171
|
+
<xs:enumeration value="53">
|
172
|
+
<xs:annotation>
|
173
|
+
<xs:documentation>Primary Oxalosis</xs:documentation>
|
174
|
+
</xs:annotation>
|
175
|
+
</xs:enumeration>
|
176
|
+
<xs:enumeration value="54">
|
177
|
+
<xs:annotation>
|
178
|
+
<xs:documentation>Fabry's disease</xs:documentation>
|
179
|
+
</xs:annotation>
|
180
|
+
</xs:enumeration>
|
181
|
+
<xs:enumeration value="59">
|
182
|
+
<xs:annotation>
|
183
|
+
<xs:documentation>Hereditary Nephropathy - Other</xs:documentation>
|
184
|
+
</xs:annotation>
|
185
|
+
</xs:enumeration>
|
186
|
+
<xs:enumeration value="60">
|
187
|
+
<xs:annotation>
|
188
|
+
<xs:documentation>congenital Renal Hypoplasia - Type Unspecified</xs:documentation>
|
189
|
+
</xs:annotation>
|
190
|
+
</xs:enumeration>
|
191
|
+
<xs:enumeration value="61">
|
192
|
+
<xs:annotation>
|
193
|
+
<xs:documentation>Oligomeganephronic Hypoplasia</xs:documentation>
|
194
|
+
</xs:annotation>
|
195
|
+
</xs:enumeration>
|
196
|
+
<xs:enumeration value="63">
|
197
|
+
<xs:annotation>
|
198
|
+
<xs:documentation>Congenital Renal Dysplasia +/- Urinary Tract Malformation</xs:documentation>
|
199
|
+
</xs:annotation>
|
200
|
+
</xs:enumeration>
|
201
|
+
<xs:enumeration value="66">
|
202
|
+
<xs:annotation>
|
203
|
+
<xs:documentation>Syndrome of Agenesis of Abdo. muscles - Prune Belly Syndrome</xs:documentation>
|
204
|
+
</xs:annotation>
|
205
|
+
</xs:enumeration>
|
206
|
+
<xs:enumeration value="70">
|
207
|
+
<xs:annotation>
|
208
|
+
<xs:documentation>Renal Vascular Disease - Type Unspecified</xs:documentation>
|
209
|
+
</xs:annotation>
|
210
|
+
</xs:enumeration>
|
211
|
+
<xs:enumeration value="71">
|
212
|
+
<xs:annotation>
|
213
|
+
<xs:documentation>Renal Vascular Disease due to MALIGNANT Hypertension</xs:documentation>
|
214
|
+
</xs:annotation>
|
215
|
+
</xs:enumeration>
|
216
|
+
<xs:enumeration value="72">
|
217
|
+
<xs:annotation>
|
218
|
+
<xs:documentation>Renal Vascular Disease due to Hypertension</xs:documentation>
|
219
|
+
</xs:annotation>
|
220
|
+
</xs:enumeration>
|
221
|
+
<xs:enumeration value="73">
|
222
|
+
<xs:annotation>
|
223
|
+
<xs:documentation>Renal Vascular Disease due to Polyarteritis</xs:documentation>
|
224
|
+
</xs:annotation>
|
225
|
+
</xs:enumeration>
|
226
|
+
<xs:enumeration value="74">
|
227
|
+
<xs:annotation>
|
228
|
+
<xs:documentation>Wegener's Granulomatosis</xs:documentation>
|
229
|
+
</xs:annotation>
|
230
|
+
</xs:enumeration>
|
231
|
+
<xs:enumeration value="75">
|
232
|
+
<xs:annotation>
|
233
|
+
<xs:documentation>Ischaemic Renal Disease/Cholesterol Embolism</xs:documentation>
|
234
|
+
</xs:annotation>
|
235
|
+
</xs:enumeration>
|
236
|
+
<xs:enumeration value="76">
|
237
|
+
<xs:annotation>
|
238
|
+
<xs:documentation>Glomerulonephritis related to liver cirrhosis</xs:documentation>
|
239
|
+
</xs:annotation>
|
240
|
+
</xs:enumeration>
|
241
|
+
<xs:enumeration value="78">
|
242
|
+
<xs:annotation>
|
243
|
+
<xs:documentation>Cryoglobulinaemic Glomerulonephritis</xs:documentation>
|
244
|
+
</xs:annotation>
|
245
|
+
</xs:enumeration>
|
246
|
+
<xs:enumeration value="79">
|
247
|
+
<xs:annotation>
|
248
|
+
<xs:documentation>Renal Vascular Disease - Classified (Please Specify)</xs:documentation>
|
249
|
+
</xs:annotation>
|
250
|
+
</xs:enumeration>
|
251
|
+
<xs:enumeration value="80">
|
252
|
+
<xs:annotation>
|
253
|
+
<xs:documentation>Diabetes Type 1 (Insulin Dependent)</xs:documentation>
|
254
|
+
</xs:annotation>
|
255
|
+
</xs:enumeration>
|
256
|
+
<xs:enumeration value="81">
|
257
|
+
<xs:annotation>
|
258
|
+
<xs:documentation>Diabetes Type 2 (Non-Insulin Dependent)</xs:documentation>
|
259
|
+
</xs:annotation>
|
260
|
+
</xs:enumeration>
|
261
|
+
<xs:enumeration value="82">
|
262
|
+
<xs:annotation>
|
263
|
+
<xs:documentation>Myelomatosis</xs:documentation>
|
264
|
+
</xs:annotation>
|
265
|
+
</xs:enumeration>
|
266
|
+
<xs:enumeration value="83">
|
267
|
+
<xs:annotation>
|
268
|
+
<xs:documentation>Amyloid</xs:documentation>
|
269
|
+
</xs:annotation>
|
270
|
+
</xs:enumeration>
|
271
|
+
<xs:enumeration value="84">
|
272
|
+
<xs:annotation>
|
273
|
+
<xs:documentation>Systemic Lupus Erythematosus</xs:documentation>
|
274
|
+
</xs:annotation>
|
275
|
+
</xs:enumeration>
|
276
|
+
<xs:enumeration value="85">
|
277
|
+
<xs:annotation>
|
278
|
+
<xs:documentation>Henoch-Schonlein Purpura</xs:documentation>
|
279
|
+
</xs:annotation>
|
280
|
+
</xs:enumeration>
|
281
|
+
<xs:enumeration value="86">
|
282
|
+
<xs:annotation>
|
283
|
+
<xs:documentation>Goodpastures Syndrome</xs:documentation>
|
284
|
+
</xs:annotation>
|
285
|
+
</xs:enumeration>
|
286
|
+
<xs:enumeration value="87">
|
287
|
+
<xs:annotation>
|
288
|
+
<xs:documentation>Scleroderma</xs:documentation>
|
289
|
+
</xs:annotation>
|
290
|
+
</xs:enumeration>
|
291
|
+
<xs:enumeration value="88">
|
292
|
+
<xs:annotation>
|
293
|
+
<xs:documentation>Haemolytic Uraemic Syndrome</xs:documentation>
|
294
|
+
</xs:annotation>
|
295
|
+
</xs:enumeration>
|
296
|
+
<xs:enumeration value="89">
|
297
|
+
<xs:annotation>
|
298
|
+
<xs:documentation>Multu-System Diseased - Type Unspecified</xs:documentation>
|
299
|
+
</xs:annotation>
|
300
|
+
</xs:enumeration>
|
301
|
+
<xs:enumeration value="90">
|
302
|
+
<xs:annotation>
|
303
|
+
<xs:documentation>Cortical or Tubula Necrosis</xs:documentation>
|
304
|
+
</xs:annotation>
|
305
|
+
</xs:enumeration>
|
306
|
+
<xs:enumeration value="91">
|
307
|
+
<xs:annotation>
|
308
|
+
<xs:documentation>Tuberculosis</xs:documentation>
|
309
|
+
</xs:annotation>
|
310
|
+
</xs:enumeration>
|
311
|
+
<xs:enumeration value="92">
|
312
|
+
<xs:annotation>
|
313
|
+
<xs:documentation>Gout</xs:documentation>
|
314
|
+
</xs:annotation>
|
315
|
+
</xs:enumeration>
|
316
|
+
<xs:enumeration value="93">
|
317
|
+
<xs:annotation>
|
318
|
+
<xs:documentation>Nephrocalcinosis / Hypercalcaemic Nephropathy</xs:documentation>
|
319
|
+
</xs:annotation>
|
320
|
+
</xs:enumeration>
|
321
|
+
<xs:enumeration value="94">
|
322
|
+
<xs:annotation>
|
323
|
+
<xs:documentation>Balkan Nephropathy</xs:documentation>
|
324
|
+
</xs:annotation>
|
325
|
+
</xs:enumeration>
|
326
|
+
<xs:enumeration value="95">
|
327
|
+
<xs:annotation>
|
328
|
+
<xs:documentation>Kidney Tumour</xs:documentation>
|
329
|
+
</xs:annotation>
|
330
|
+
</xs:enumeration>
|
331
|
+
<xs:enumeration value="96">
|
332
|
+
<xs:annotation>
|
333
|
+
<xs:documentation>Traumatic or Surgical Loss of Kidney</xs:documentation>
|
334
|
+
</xs:annotation>
|
335
|
+
</xs:enumeration>
|
336
|
+
<xs:enumeration value="99">
|
337
|
+
<xs:annotation>
|
338
|
+
<xs:documentation>Other identified Renal Disorders - Please Specify</xs:documentation>
|
339
|
+
</xs:annotation>
|
340
|
+
</xs:enumeration>
|
341
|
+
|
342
|
+
<!-- TODO: EDTA2 Codes will go here -->
|
343
|
+
|
344
|
+
</xs:restriction>
|
345
|
+
</xs:simpleType>
|
346
|
+
</xs:element>
|
347
|
+
<xs:element name="Description" minOccurs="0">
|
348
|
+
<xs:simpleType>
|
349
|
+
<xs:restriction base="xs:string">
|
350
|
+
<xs:maxLength value="32000"/>
|
351
|
+
</xs:restriction>
|
352
|
+
</xs:simpleType>
|
353
|
+
</xs:element>
|
354
|
+
</xs:sequence>
|
355
|
+
</xs:complexType>
|
356
|
+
</xs:schema>
|
@@ -0,0 +1,76 @@
|
|
1
|
+
<xs:schema xmlns="http://www.rixg.org.uk/" xmlns:xs="http://www.w3.org/2001/XMLSchema" targetNamespace="http://www.rixg.org.uk/">
|
2
|
+
<xs:complexType name="CF_HL7_0004">
|
3
|
+
<xs:sequence>
|
4
|
+
<xs:element name="CodingStandard" minOccurs="0">
|
5
|
+
<xs:simpleType>
|
6
|
+
<xs:restriction base="xs:string">
|
7
|
+
<xs:enumeration value="HL7_0004"/>
|
8
|
+
</xs:restriction>
|
9
|
+
</xs:simpleType>
|
10
|
+
</xs:element>
|
11
|
+
<xs:element name="Code" minOccurs="0">
|
12
|
+
<xs:simpleType>
|
13
|
+
<xs:restriction base="xs:string">
|
14
|
+
<xs:enumeration value="E">
|
15
|
+
<xs:annotation>
|
16
|
+
<xs:documentation>Emergency</xs:documentation>
|
17
|
+
</xs:annotation>
|
18
|
+
</xs:enumeration>
|
19
|
+
<xs:enumeration value="I">
|
20
|
+
<xs:annotation>
|
21
|
+
<xs:documentation>Inpatient</xs:documentation>
|
22
|
+
</xs:annotation>
|
23
|
+
</xs:enumeration>
|
24
|
+
<xs:enumeration value="O">
|
25
|
+
<xs:annotation>
|
26
|
+
<xs:documentation>Outpatient</xs:documentation>
|
27
|
+
</xs:annotation>
|
28
|
+
</xs:enumeration>
|
29
|
+
<xs:enumeration value="P">
|
30
|
+
<xs:annotation>
|
31
|
+
<xs:documentation>Preadmit</xs:documentation>
|
32
|
+
</xs:annotation>
|
33
|
+
</xs:enumeration>
|
34
|
+
<xs:enumeration value="R">
|
35
|
+
<xs:annotation>
|
36
|
+
<xs:documentation>Recurring Patient</xs:documentation>
|
37
|
+
</xs:annotation>
|
38
|
+
</xs:enumeration>
|
39
|
+
<xs:enumeration value="B">
|
40
|
+
<xs:annotation>
|
41
|
+
<xs:documentation>Obstetrics</xs:documentation>
|
42
|
+
</xs:annotation>
|
43
|
+
</xs:enumeration>
|
44
|
+
<xs:enumeration value="D">
|
45
|
+
<xs:annotation>
|
46
|
+
<xs:documentation>Day Hospital</xs:documentation>
|
47
|
+
</xs:annotation>
|
48
|
+
</xs:enumeration>
|
49
|
+
<xs:enumeration value="W">
|
50
|
+
<xs:annotation>
|
51
|
+
<xs:documentation>Week Hospital</xs:documentation>
|
52
|
+
</xs:annotation>
|
53
|
+
</xs:enumeration>
|
54
|
+
<xs:enumeration value="S">
|
55
|
+
<xs:annotation>
|
56
|
+
<xs:documentation>Psychiatric</xs:documentation>
|
57
|
+
</xs:annotation>
|
58
|
+
</xs:enumeration>
|
59
|
+
<xs:enumeration value="K">
|
60
|
+
<xs:annotation>
|
61
|
+
<xs:documentation>Newborn</xs:documentation>
|
62
|
+
</xs:annotation>
|
63
|
+
</xs:enumeration>
|
64
|
+
</xs:restriction>
|
65
|
+
</xs:simpleType>
|
66
|
+
</xs:element>
|
67
|
+
<xs:element name="Description" minOccurs="0">
|
68
|
+
<xs:simpleType>
|
69
|
+
<xs:restriction base="xs:string">
|
70
|
+
<xs:maxLength value="32000"/>
|
71
|
+
</xs:restriction>
|
72
|
+
</xs:simpleType>
|
73
|
+
</xs:element>
|
74
|
+
</xs:sequence>
|
75
|
+
</xs:complexType>
|
76
|
+
</xs:schema>
|
@@ -0,0 +1,46 @@
|
|
1
|
+
<xs:schema xmlns="http://www.rixg.org.uk/" xmlns:xs="http://www.w3.org/2001/XMLSchema" targetNamespace="http://www.rixg.org.uk/">
|
2
|
+
<xs:complexType name="CF_HL7_00204">
|
3
|
+
<xs:sequence>
|
4
|
+
<xs:element name="CodingStandard" minOccurs="0">
|
5
|
+
<xs:simpleType>
|
6
|
+
<xs:restriction base="xs:string">
|
7
|
+
<xs:enumeration value="HL7_00204"/>
|
8
|
+
</xs:restriction>
|
9
|
+
</xs:simpleType>
|
10
|
+
</xs:element>
|
11
|
+
<xs:element name="Code" minOccurs="0">
|
12
|
+
<xs:simpleType>
|
13
|
+
<xs:restriction base="xs:string">
|
14
|
+
<xs:enumeration value="DA">
|
15
|
+
<xs:annotation>
|
16
|
+
<xs:documentation>Drug Allergy</xs:documentation>
|
17
|
+
</xs:annotation>
|
18
|
+
</xs:enumeration>
|
19
|
+
<xs:enumeration value="FA">
|
20
|
+
<xs:annotation>
|
21
|
+
<xs:documentation>Food Allergy</xs:documentation>
|
22
|
+
</xs:annotation>
|
23
|
+
</xs:enumeration>
|
24
|
+
<xs:enumeration value="MA">
|
25
|
+
<xs:annotation>
|
26
|
+
<xs:documentation>Miscellaneous Allergy</xs:documentation>
|
27
|
+
</xs:annotation>
|
28
|
+
</xs:enumeration>
|
29
|
+
<xs:enumeration value="MC">
|
30
|
+
<xs:annotation>
|
31
|
+
<xs:documentation>Miscellaneous Contraindication</xs:documentation>
|
32
|
+
</xs:annotation>
|
33
|
+
</xs:enumeration>
|
34
|
+
</xs:restriction>
|
35
|
+
</xs:simpleType>
|
36
|
+
</xs:element>
|
37
|
+
<xs:element name="Description" minOccurs="0">
|
38
|
+
<xs:simpleType>
|
39
|
+
<xs:restriction base="xs:string">
|
40
|
+
<xs:maxLength value="32000"/>
|
41
|
+
</xs:restriction>
|
42
|
+
</xs:simpleType>
|
43
|
+
</xs:element>
|
44
|
+
</xs:sequence>
|
45
|
+
</xs:complexType>
|
46
|
+
</xs:schema>
|